京都医療センター

臨床研究センター

内分泌代謝高血圧研究部

発表論文

2023年

  • Kusakabe T, Arai H, Yamamoto Y, Nakao K, Akamatsu Y, Ishihara Y, Tagami T, Yasoda A, Satoh-Asahara N. Cross-sectional association of skeletal muscle mass and strength with dietary habits and physical activity among first-year university students in Japan: Results from KEIJI-U study. Nutrition, in Press, 2023.
  • Wakabayashi D, Kato S, Tanaka M, Yamakage H, Kato H, Kusakabe T, Ozu N, Kasama S, Kasahara M, and Satoh-Asahara N, The Japan Obesity Metabolic Syndrome Study (JOMS) Group. Novel pathological implications of serum uric acid with cardiovascular disease risk in obesity. Diabetes Res Clin Prac, 205: 110919, 2023.
  • Ikeue K, Kusakabe T, Yamakage H, Ishii K, Satoh-Asahara N. A Body Shape Index is useful for BMI-independently identifying Japanese patients with obesity at high risk of cardiovascular disease. Nutr Metab Cardiovasc Dis, in Press, 2023.
  • Uno-Eder K, Satoh-Asahara N, Hibiya M, Uno K, Uchino T, Morita1 K, Ishikawa T, Kaneko T, Yamakage H, Kitaoka Y, Sawa T, Tsukamoto K, Teramoto T. Understanding Impacts of COVID-19 Restrictions on Glycemic Control for Patients with Diabetes in Japan. J Diabetes Metab Disord, 22:1, 2023.
  • Kawai S, Yamakage H, Kotani K, Noda M, Satoh-Asahara N, Hashimoto K. Differences in metabolic characteristics between Metabolically Healthy Obesity (MHO) and Metabolically Unhealthy Obesity (MUO) in weight reduction therapy. Endocrine Journal, 9 EJ23-018, 2023.
  • Iwasa M, Kato H, Iwashita K, Yamakage H, Kato S, Saito S, Ihara M, Nishimura H, Kawamoto A, Suganami T, Tanaka M, Satoh-Asahara N. Taxifolin Suppresses Inflammatory Responses of High- Glucose-Stimulated Mouse Microglia by Attenuating the TXNIP–NLRP3 Axis. Nutrients,15:12, 2738, 2023.
  • Kitamura T, Ishihara Y, Kusakabe T, Tsuiki M, Nanba K, Hiroshima-Hamanaka K, Satoh-Asahara N, Yasoda A, Tagami T. A case of osteogenesis imperfecta caused by COL1A1 mutations, coexisting with pituitary stalk interruption syndrome. Endocr J, EJ22-0564, 2023.
  • Inoue T, Fu B, Nishio M, Tanaka M, Kato H, Tanaka M, Itoh M, Yamakage H, Ochi K, Ito A, Shiraki Y, Saito S, Ihara M, Nishimura H, Kawamoto A, Inoue S, Saeki K, Enomoto A, Suganami T, Satoh-Asahara N. Novel Therapeutic Potentials of Taxifolin for Obesity-Induced Hepatic Steatosis, Fibrogenesis, and Tumorigenesis. Nutrients, 15: 350, 2023.